Table 2. Clinicopathological characteristics of patients stratified by CRP/Alb ratio.
| Variables | CRP/Alb ratio ≥0.441, n (%) | CRP/Alb ratio <0.441, n (%) | P value |
|---|---|---|---|
| Age( years) | 0.659 | ||
| <59 | 108 (66.7) | 54 (33.3) | |
| ≥59 | 131 (63.9) | 74 (36.1) | |
| Gender | 0.637 | ||
| Male | 204 (64.6) | 112 (35.4) | |
| Female | 35 (68.6) | 16 (31.4) | |
| Smoking | 0.669 | ||
| smoker | 195 (64.6) | 107 (35.4) | |
| Never smoker | 44 (67.7) | 21 (32.3) | |
| PS at diagnosis | 0.734 | ||
| 0 | 130 (66.7) | 65 (33.3) | |
| 1 | 91 (64.1) | 51 (35.9) | |
| 2 | 18 (60.0) | 12 (40.0) | |
| Stage | 0.584 | ||
| Limited disease | 120 (66.7) | 60 (33.3) | |
| Extensive disease | 119 (63.6) | 68 (36.4) | |
| LDH at diagnosis, U/L | 0.010 | ||
| Normal range | 155 (70.5) | 65 (29.5) | |
| Abnormally elevated | 84 (57.1) | 63 (42.9) | |
| Chemotherapy regimen | 0.432 | ||
| Etoposide-based | 208 (66.0) | 107 (34.0) | |
| others | 31 (59.6) | 21 (40.4) | |
| Prophylactic cranial irradiation | 0.793 | ||
| Yes | 185 (64.7) | 101 (35.3) | |
| No | 54 (66.7) | 27 (33.3) |
Abbreviations: PS, performance status; LDH, lactate dehydrogenase; CRP/Alb, C-reactive protein / albumin.